Longboard pharmaceuticals to participate in upcoming investor events

San diego, may 12, 2022 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior leadership team will participate in the citi movement disorder & epilepsy co-panel, on may 18, 2022, and present virtually in a fireside chat format at the h.c. wainwright global investment hybrid conference, which is taking place may 23-26, 2022.
LBPH Ratings Summary
LBPH Quant Ranking